Upcoming Events

Influenza mRNA Vaccines: Mechanisms and Methodologies

Venue: Virtual
Date: Jul 22, 2022 - Jul 22, 2022
Title: Influenza mRNA Vaccines: Mechanisms and Methodologies
Date: July 27, 2022
Time: 8am PT, 11pm ET, 17:00 CET
Duration: 1 Hour

Featured Speakers:
Norbert Pardi, Ph.D.
The power of mRNA vaccines became well established due to the COVID-19 pandemic, but we are just beginning to scratch the surface of their therapeutic versatility. Numerous global projects are underway to employ mRNA technology to combat human diseases such as cancer, HIV, and influenza. In a four-part webinar series over the next several months, we will hear from a diverse group of investigators who are at the vanguard of mRNA research and the novel ways they are utilizing this technology. In this first webinar, which GEN and The CRISPR Journal are co-hosting, our distinguished speaker will be Dr. Norbert Pardi, who has been doing some excellent, cutting-edge work on the development of broadly protective mRNA-based influenza vaccines. Not only will he discuss the mechanism of action of mRNA vaccines, Dr. Pardi will also tell us how his laboratory utilized a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine platform to deliver a combination of conserved influenza virus antigens.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

Register Now

2nd mRNA-Based Therapeutics Summit USA

Venue: Hilton Boston Logan Airport, Boston, MA, USA
Date: Jul 26, 2022 - Jul 28, 2022
The most anticipated event of the mRNA calendar, the mRNA-Based Therapeutics Summit is returning for its second year this July as the comprehensive, industry-leading meeting for mRNA experts; your one-stop-shop for all your mRNA-based vaccine and therapeutic needs. Access exclusive data from the movers and shakers in mRNA vaccine and therapy development. 400+ pioneers from the likes of Pfizer, Moderna, Sanofi, Arcturus Therapeutics, Nutcracker Therapeutics, and more are reuniting at the world’s only end-to-end meeting focused on the development of mRNA vaccines and therapies from early basic research through to commercialization and to the patients in need.

You can find TriLink at booth #9.

Featured Presentation
Date: July 27, 2022
Time: 2:00 p.m. ET / 11:00 a.m. PT
Title:Quality Attributes to Support the Development of mRNA

Featured Speaker:
Khaled Yamout
Senior Director Manufacturing & Quality Control, TriLink BioTechnologies

Talking Points: 1. mRNA as a biological molecule 2. Selecting quality attributes for the characterization of mRNA 3. Method development for testing and characterization of mRNA
Schedule a meeting with us

Register Now